Justin Olshavsky
General Partner at Pioneer Fund
United States
Overview
Work Experience
General Partner, Bio+Health Fund
2023 - Current
Founding GP of Pioneer Fund's Bio+Health focused fund. Investing in pre-seed and seed stage biotechnology, life science, and healthcare companies. Please reach out if you're building in bio+health!
Entrepreneur-in-Residence
2021 - 2022
Focus on Bio+Health
Venture Partner
2020 - 2021
Venture Partner - 10/2020-01/2021 Senior Venture Partner - 01/2021-11/2021
Building
2023
Pressing pause on biological time.
Cradle is a cryonics company that develops and proves the feasibility of human organs and whole-body reversible cryopreservation.
Raised $48,000,000.00.
Entrepreneur-in-Residence
2024
Neuroprotection
2020 - 2023
Transitioning the Voyage technology to Penumbra post-acquisition
Penumbra develops clinically beneficial products that help patients suffering from stroke and other neurovascular diseases.
Raised $2,871,226.00 from The Halo Fund.
Co-founder and CTO
2018 - 2023
Hypothermia to end brain damage from stroke. Y Combinator S19. Voyage was acquired by Penumbra (NYSE:PEN)
Voyage Biomedical is a medical device startup.
Raised $150,000.00 from Y Combinator, SkyDeck Berkeley and Creative Destruction Lab (CDL).
Robotics Engineer
2017 - 2018
Bomb-disposal robots, robotic systems for satellites
Harris Corp - composite aero-structures division is a supplier of advanced composite products primarily for airframe applications.
Biomechanics Research
2016 - 2016
Simulating artificial heart valves in silico
Mechanical Engineering Intern
2014 - 2014
Nuclear energy